Alprazolam

Active ingredient description

Alprazolam, like other benzodiazepines, has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post synaptic inhibition in the central nervous system (CNS).

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
N05BA12
Alprazolam
N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA12

Medicines

Alprazolam is the active ingredient of these drugs:

Drug
Countries
ALPRANAX

Hong Kong

ALPRASEDON

Lithuania

ALPRASTAD

Austria

ALPRAX

Australia Hong Kong

APRAZ

Brazil

FRONTAL

Brazil

FRONTIN

Lithuania

GERAX

Ireland

KALMA

Australia Hong Kong

NALION

Cyprus Hong Kong

RENAX

Cyprus

TAFIL

Germany

TEUFRON

Brazil

TRANKIMAZIN

Spain

TRANQUINAL

Brazil

XANAX

Canada Cyprus France Hong Kong Ireland

XANOR

Austria

ZACETIN

Singapore

ZOLARAM

Cyprus Hong Kong

ZOMIREN

Lithuania

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
XANAX Tablets
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

YU55MQ3IZY - ALPRAZOLAM

CAS registry number

28981-97-7 - alprazolam

SNOMED-CT

386983007 - Alprazolam (substance)

Next: Usage